Home > Search Results
  • We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Background

Pharmalgen® products (ALK Abelló) are used for the diagnosis and treatment of immunoglobulin E (IgE)-mediated allergy to bee and wasp venom. The aim of this systematic review was to assess whether use of Pharmalgen products is of clinical value when providing VIT to individuals with a history of severe reaction to bee and wasp venom, and whether it would be considered cost-effective compared with alternative treatment options available in the NHS in England and Wales.

Recent Activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...